PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
01-May-2023 Horizon Therapeutics plc Announces Initiation of Phase 3 Clinical Trial in Japan Evaluating TEPEZZA® (teprotumumab-trbw) in Adults with Chronic/Low Clinical Activity Score (CAS) Thyroid Eye Disease (TED) Businesswire
01-May-2023 Aptorum Therapeutics Limited Enters Into Letter of Intent and Term Sheet with Universal Sequencing Technology Corporation to Merge with Aptorum Group’s Subsidiary Paths Innovations Limited Businesswire
01-May-2023 Inspirna Appoints Dr. Usman “Oz” Azam, M.D., as New Chief Executive Officer Businesswire
01-May-2023 Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID Businesswire
01-May-2023 bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer Businesswire
01-May-2023 OmniAb to Report First Quarter 2023 Financial Results on May 11 Businesswire
01-May-2023 COEUS Holdings Announces Rebranding to Reflect the Unification of Each Business Unit Into One Entity Businesswire
01-May-2023 U.S. FDA Accepts for Priority Review Supplemental Biologics License Application and EMA Validates Application for Reblozyl® (luspatercept-aamt) as First-Line Treatment of Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (MDS) Businesswire
01-May-2023 Great Point Partners Expands Transatlantic Value Creation Through London Office Opening Businesswire
01-May-2023 Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Society of Cataract and Refractive Surgery Annual Meeting Businesswire
01-May-2023 Silence Therapeutics Completes Enrollment in Phase 2 Study of Zerlasiran (SLN360) in Subjects with Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events Businesswire
01-May-2023 Bristol Myers Squibb’s TRANSCEND FL and TRANSCEND NHL 001 Studies of Breyanzi (lisocabtagene maraleucel) in Relapsed or Refractory Follicular Lymphoma and Mantle Cell Lymphoma Meet Primary Endpoint of Overall Response Rate Businesswire
01-May-2023 NovaBay Pharmaceuticals Fulfills $1 Million Order for NeutroPhase® Skin and Wound Cleanser for China Pioneer Pharma Holdings Businesswire
01-May-2023 Global Custom Synthesis & Manufacturing (CSM) Market Report 2023: Escalating Demand for Specialty Chemicals Drives Growth - ResearchAndMarkets.com Businesswire
01-May-2023 Global Digestive Remedies Market 2023: Sector is Expected to Reach $22.53 Billion by 2028 at a CAGR of 3.3% - ResearchAndMarkets.com Businesswire
01-May-2023 Astellas Enters Into Definitive Agreement to Acquire Iveric Bio Businesswire
28-Apr-2023 Vinod Lakhani Appointed as New CEO of Chronicled, the Company Behind the MediLedger Blockchain Network Newswire
27-Apr-2023 New genotype tests reveal most Brits have Neanderthal DNA – and all of us are immigrants London Medical Laboratory
27-Apr-2023 D2V Clinical: Raising the Bar for Early-Phase Oncology Newswire
25-Apr-2023 Seraxis Presents Successful Results Using Synthetic Replacement Endocrine Clusters for Type 1 Diabetes at the 4th IPITA / HSCI / JDRF Summit Newswire